Download PDF

Other users also viewed these articles

Methylene tetrahydrofolate reductase (MTHFR) and vascular endothelial growth factor (VEGF) polymorphisms in Brazilian patients with Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) Sylene C.R. Carvalho; Luydson R.S. Vasconcelos; Leonardo da Fonseca; Rodrigo F. Carmo; Michele T. Tomitão; Dayse C.B.L. Aroucha; Leila M.M.B. Pereira; José Tadeu Stefano; Ulysses Ribeiro-Júnior; Claudia P. Oliveira; Flair J. Carrilho;
Clinics. 2021;76C:
SESTD1 as a potential prognostic biomarker associated with tumor aggressiveness and immune infiltration in hepatocellular carcinoma Ying Liu; Taoying Chen; Li Tang; Daqing Cheng; Ming Xu; Jiaoxiang Wu; Bingyan Liu; Hao Cheng; Bo Han; Yu Zhang; Sheng Cheng;
10.1016/j.clinsp.2025.100796
The impact of the PNPLA3 rs738406 C>G polymorphism on hepatocellular carcinoma risk in Brazilian patients with chronic hepatitis C and advanced fibrosis Claudia Maccali; Isabel Veloso Alves Pereira; Lisa Rodrigues da Cunha Saud; Regiane Saraiva de Souza Melo Alencar; Arthur Ivan Nobre Oliveira; Jose Tadeu Stefano; Michele Soares Gomes Gouvea; Joyce Matie Kinoshita da Silva Etto; Paulo Herman; João Renato Rebello Pinho; Rafael Soares Nunes Pinheiro; Wellington Andraus; Luiz Augusto Carneiro D¿Albuquerque; Mario Guimarães Pessoa; Aline Lopes Chagas; Claudia Pinto Marques Souza de Oliveira;
10.1016/j.clinsp.2025.100797